Bond Bausch Health Companies 11% ( USC07885AL76 ) in USD
| Issuer | Bausch Health Companies | ||||||||||||||||||||
| Market price | |||||||||||||||||||||
| Country | Canada
|
||||||||||||||||||||
| ISIN code |
USC07885AL76 ( in USD )
|
||||||||||||||||||||
| Interest rate | 11% per year ( payment 2 times a year) | ||||||||||||||||||||
| Maturity | 30/09/2028 | ||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||
| Minimal amount | 1 000 USD | ||||||||||||||||||||
| Total amount | 1 774 067 000 USD | ||||||||||||||||||||
| Cusip | C07885AL7 | ||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | B- ( Highly speculative ) | ||||||||||||||||||||
| Moody's rating | Caa1 ( Substantial risks ) | ||||||||||||||||||||
| Next Coupon | 30/09/2026 ( In 17 days ) | ||||||||||||||||||||
| Detailed description |
Bausch Health Companies is a global pharmaceutical company focused on developing, manufacturing, and marketing a range of pharmaceutical, ophthalmological, and consumer healthcare products. Bausch Health Companies (USD) 11% bonds due September 30, 2028 (CUSIP: C07885AL7, ISIN: USC07885AL76), with a total issuance size of $1,774,067,000 and a minimum purchase size of $1,000, are currently trading at 91.24% of par value, paying semi-annually, and rated B- by S&P and Caa1 by Moody's. |
||||||||||||||||||||
| |||||||||||||||||||||
Français
Italiano
Canada